Madrigal Pharmaceuticals, Inc. (MDGL) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was…
Source: Yahoo Finance
Sector & Industry
Madrigal Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Madrigal Pharmaceuticals, Inc. at a Glance
| Company | Madrigal Pharmaceuticals, Inc. |
| Ticker | MDGL |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $541.08 |
| Market cap | $12.50B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$14.00 |
| 52-week high | $615.00 |
| 52-week low | $393.61 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | -0.99 |
| Return on equity (ROE) | -53.31% |
| Debt-to-equity | 66.40% |
| Average volume | 349,642 |
| Shares outstanding | 23.10M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 915 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Madrigal Pharmaceuticals, Inc.'s current P/E ratio?
- Madrigal Pharmaceuticals, Inc. (MDGL) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Madrigal Pharmaceuticals, Inc.'s market capitalisation?
- Madrigal Pharmaceuticals, Inc.'s market cap is $12.50B based on our latest snapshot. See how it ranks by market cap →
- What is MDGL's 52-week range?
- Over the past 52 weeks, MDGL has traded between $393.61 and $615.00. What does the 52-week range mean? →
- How volatile is Madrigal Pharmaceuticals, Inc. compared to the market?
- Madrigal Pharmaceuticals, Inc. has a beta of -0.99, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Madrigal Pharmaceuticals, Inc. pay a dividend?
- Madrigal Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is MDGL listed on?
- MDGL is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Madrigal Pharmaceuticals, Inc. in?
- Madrigal Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →